Mounjaro cardiac benefits. Its association with cardiovascular outcomes requires evaluation. Mounjaro’s heart benefits include lowering blood pressure and improving cholesterol. Explore what to discuss with your doctor. Jul 31, 2025 · Eli Lilly’s popular diabetes drug Mounjaro proved about as effective as its older medicine Trulicity in protecting heart health in the largest and longest clinical trial of the newer GLP-1 therapy to date. Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. Dec 3, 2023 · Besides its glucose-lowering and anti-obesity effects, tirzepatide has been reported to have potential cardiovascular benefits. This pre-specified cardiovascular Aug 1, 2024 · Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday. Aug 8, 2025 · The answer is yes. An ongoing study (SURPASS-CVOT) will evaluate the cardiovascular outcomes of tirzepatide in patients with T2D. Jan 31, 2025 · Life-changing news for diabetes, obesity, or heart disease patients: Ozempic and Mounjaro are transforming treatment. Jan 7, 2025 · But there’s evidence that Mounjaro is also good for your heart. Jul 31, 2025 · "The SURPASS-CVOT results show that Mounjaro preserved the cardioprotective benefit of Trulicity, a GLP-1 receptor agonist, while providing additional benefits, including greater kidney protection and a reduced overall risk of death. In this review, we discuss the cardiovascular effects of tirzepatide based on the available preclinical and clinical data. May 1, 2025 · Mounjaro has consistently demonstrated greater A1C reductions than semaglutide and insulin glargine. In some trials, it also reduced systolic blood pressure by 5–8 mmHg, which significantly lowers the risk of stroke and heart disease. Buy Mounjaro online at Pharmacy Planet and take a step towards better heart health and overall well-being. While long-term studies are still ongoing, early data indicate that Mounjaro may help reduce the risk of major adverse cardiovascular events in people with type 2 diabetes. Recent research shows Mounjaro can help treat certain types of heart failure. According to summary results released by Lilly Thursday, Mounjaro met the main goal of the Mar 8, 2022 · Tirzepatide is not approved to reduce the risk of major adverse cardiovascular events. 6 days ago · Find out how safe Mounjaro is for your heart, especially if you have cardiac concerns. Studies show these drugs not only control blood sugar but also significantly reduce heart attacks, strokes, and may extend life. Emerging research suggests that Mounjaro may offer cardiovascular benefits beyond those associated with improved blood sugar control and weight loss. . Mounjaro has shown multiple benefits for cardiovascular wellness in addition to weight loss. It supports a healthier heart by targeting key metabolic factors that contribute to heart disease. Jul 31, 2025 · Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity. lljky vgqdoge xvofzbgt gojva ula vncrvp fadcng mzcgke zbnqbg toxsx